Steven Hetts, MD
|School||UCSF School of Medicine|
|Address||505 Parnassus Avenue|
San Francisco CA 94117
|University of California, San Francisco||Fellowship||School of Medicine - Interventional Neuroradiology|
|University of California, San Francisco||Fellowship||School of Medicine - Diagnostic Neuroradiology|
|University of California, San Francisco||Residency||School of Medicine - Radiology|
|Harvard University||M.D.||2000||School of Medicine|
|UCSF Department of Radiology and Biomedical Imaging||2016||Excellence in Medical Student Teaching Award|
|University of California, San Francisco||2016||Catalyst Award|
|Rosenman Institute for Medical Device Innovation||2015||Fellow|
|California Institute for Quantitative Biosciences (QB3)||2015||Nominee, Best Medical Device Start-Up Company, ChemoFilter|
|University of California, San Francisco ||2013||Catalyst Award |
|American Society of Neuroradiology||2011||Neuroradiology Education and Research Foundation Scholar Award in Neuroradiology Research|
|International Society for Magnetic Resonance in Medicine Annual Meeting, Montreal, Canada||2011||First Prize Poster, Interventional Category|
|American Society of Neuroradiology||2010||Neuroradiology Education and Research Foundation Scholar Award|
|American Roentgen Ray Society||2005||Executive Council Award, Residents in Radiology Competition|
|American Society of Pediatric Neuroradiology||2004||Annual Research Award|
|Margulis Society Radiology ||2002
||2003||Resident Research Award|
|Department of Internal Medicine, Stanford Hospital||2001||Nominee, Resident Teaching Award|
|Harvard Medical School||1997||Ebert Community Service Award|
Steven Hetts, MD is Chief of Interventional Neuroradiology at the UCSF Mission Bay Hospitals, where he provides cutting-edge, minimally invasive endovascular therapy for children and adults with stroke, cerebrovascular disease and tumors, including retinoblastoma. He founded the Interventional Neuroradiology services at San Francisco General Hospital and the San Francisco Veteran’s Administration Hospital, where he served as Chief until 2015. Throughout his career, Dr. Hetts has maintained an active clinical practice at UCSF Parnassus, treating patients with stroke, brain aneurysms, arteriovenous malformations, dural arteriovenous fistulas, spinal vascular malformations, and tumors including meningioma. Dr. Hetts is also the founding Co-Director of the UCSF Hereditary Hemorrhagic Telangiectasia Center of Excellence wherein he and his colleagues provide care for patients with vascular malformations of the brain, severe nosebleeds (epistaxis), and arteriovenous malformations of the lung and other organs. Dr. Hetts received his MD from Harvard Medical School and his undergraduate degree from Harvard College. He completed his medical internship at Stanford and his diagnostic radiology residency, diagnostic neuroradiology fellowship, and interventional neuroradiology fellowship at UCSF, where he joined the faculty in 2008.
As Co-Director of the Interventional Radiology Research Laboratory, Dr. Hetts is involved in translating basic science and engineering research into clinical applicability. The main theme of his research is development of novel image-guided endovascular devices and techniques for the treatment of stroke, tumors, vascular malformations, and other conditions accessible through the blood vessels or skin. He has been the principal investigator on an NIH-sponsored project to develop remote-controlled endovascular catheters for use in interventional MRI. This could revolutionize stroke treatment, allowing doctors to visualize living versus dead brain tissue in real-time during their surgeries. He is also the principal investigator on an NIH-sponsored project to develop an endovascular filtration device to reduce systemic toxicity during intraarterial chemotherapy for a variety of tumors. Such a device could not only reduce the side-effects of chemotherapy, but also enable better tumor control and, in some cases, cure. Dr. Hetts’ research projects have received over $4.5 million in federal and foundation funding and he was appointed chair of an NIH study section evaluating innovative neurological technologies in 2016.
Dr. Hetts has published over 130 peer-reviewed articles and book chapters. He has lectured on interventional neuroradiology clinical practice and research on six continents. With colleagues in the IR Research Lab, Dr. Hetts helped form a startup company, ChemoFilter, to develop endovascular filtration devices. This company was nominated for Medical Device Startup Company of the Year in the First Annual California Quantitative Biology Awards in 2015 and was acquired that year by Penumbra, Inc, an Alameda-based maker of endovascular devices. In 2015, Dr. Hetts was named a Fellow of the Rosenman institute at QB3 and advises other UCSF faculty and affiliates on developing translational research to bring innovative ideas to patient care.
Neuro Interventional Radiology
Brain, spine, head and neck
Interventional neuroradiology, neurointerventional radiology, neurointerventional surgery, pediatric neuroradiology, diagnostic neuroradiology, interventional MRI, interventional neuro-oncology
Education and Training:
• Medical School: Harvard Medical School, Boston, Massachusetts
• Internship: Stanford University, California - Internal Medicine
• Residency: University of California, San Francisco - Diagnostic Radiology
• Fellowship: University of California, San Francisco - Diagnostic Neuroradiology
• Fellowship: University of California, San Francisco - Interventional Neuroradiology
• Physician and Surgeon, Medical Board of California
• Radiology X-Ray Supervisor and Operator, California Department of Health Services
• Board Certified in Diagnostic Radiology, American Board of Radiology
• Subspecialty Certification (CAQ) in Neuroradiology, American Board of Radiology
• Basic Life Support Certification (BLS), American Heart Association
• Advanced Cardiac Life Support Certification (ACLS), American Heart Association
Derived automatically from this person's publications.
People in Profiles who have published with this person.
People who share related concepts with this person.